Abstract: Apparatuses and methods for a self-deploying tree are disclosed. In an exemplary embodiment, a self-deploying tree system comprises a top tree assembly, a main tree assembly, and a base. The lower end of the top tree assembly may be coupled to the upper end of the main tree assembly, and the lower end of the main tree assembly may be coupled to the base, providing a vertical orientation of the self-deploying tree system. The self-deploying tree system further comprises a deployment mechanism which may be activated to automatically convert the tree from a collapsed configuration to a deployed configuration or from a deployed configuration to a collapsed configuration. The collapsed configuration comprises a reduced height and a reduced circumference to allow for ease of handling and storage. The deployed configuration provides for the tree to be extended to a desired height and for deployment of the limbs as desired for display.

Abstract: Disclosed herein are methods for quantifying contact lens deposition. An example method may comprise disposing a contact lens sample in a fluid well. The example method may comprise disposing a volume of tear fluid in the well with the contact lens sample. The example method may comprise capturing pre-rinse images of the contact lens sample. The example method may comprise rinsing the contact lens sample. The example method may comprise capturing post-rinse images of the contact lens after the rinsing. The example method may comprise determining, using one or more of the tear images or the post-rinse images, a deposition metric. The example method may comprise outputting the deposition metric.

Abstract: Disclosed herein are methods for quantifying contact lens deposition. An example method may comprise disposing a contact lens sample in a fluid well. The example method may comprise disposing a volume of tear fluid in the well with the contact lens sample. The example method may comprise capturing pre-rinse images of the contact lens sample. The example method may comprise rinsing the contact lens sample. The example method may comprise capturing post-rinse images of the contact lens after the rinsing. The example method may comprise determining, using one or more of the tear images or the post-rinse images, a deposition metric. The example method may comprise outputting the deposition metric.

Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.

Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.

Abstract: Apparatuses and methods for a self-deploying tree are disclosed. In an exemplary embodiment, a self-deploying tree system comprises a top tree assembly, a main tree assembly, and a base. The lower end of the top tree assembly may be coupled to the upper end of the main tree assembly, and the lower end of the main tree assembly may be coupled to the base, providing a vertical orientation of the self-deploying tree system. The self-deploying tree system further comprises a deployment mechanism which may be activated to automatically convert the tree from a collapsed configuration to a deployed configuration or from a deployed configuration to a collapsed configuration. The collapsed configuration comprises a reduced height and a reduced circumference to allow for ease of handling and storage. The deployed configuration provides for the tree to be extended to a desired height and for deployment of the limbs as desired for display.

Abstract: Apparatuses and methods for a self-deploying tree are disclosed. In an exemplary embodiment, a self-deploying tree system comprises a top tree assembly, a main tree assembly, and a base. The lower end of the top tree assembly may be coupled to the upper end of the main tree assembly, and the lower end of the main tree assembly may be coupled to the base, providing a vertical orientation of the self-deploying tree system. The self-deploying tree system further comprises a deployment mechanism which may be activated to automatically convert the tree from a collapsed configuration to a deployed configuration or from a deployed configuration to a collapsed configuration. The collapsed configuration comprises a reduced height and a reduced circumference to allow for ease of handling and storage. The deployed configuration provides for the tree to be extended to a desired height and for deployment of the limbs as desired for display.

Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.

Abstract: Apparatuses and methods for a self-deploying tree are disclosed. In an exemplary embodiment, a self-deploying tree system comprises a top tree assembly, a main tree assembly, and a base. The lower end of the top tree assembly may be coupled to the upper end of the main tree assembly, and the lower end of the main tree assembly may be coupled to the base, providing a vertical orientation of the self-deploying tree system. The self-deploying tree system further comprises a deployment mechanism which may be activated to automatically convert the tree from a collapsed configuration to a deployed configuration or from a deployed configuration to a collapsed configuration. The collapsed configuration comprises a reduced height and a reduced circumference to allow for ease of handling and storage. The deployed configuration provides for the tree to be extended to a desired height and for deployment of the limbs as desired for display.

Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.

Abstract: A pen-injector device comprising an anti-IL-6 antibody with a liquid formulation have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: A pen-injector device comprising an anti-IL-6 antibody with a liquid formulation have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: Methods of treating disorders related to CXCL13 activity utilize CXCL13 antagonists and, optionally, TNF? antagonists, such as antibodies, including specified portions or variants, polypeptides, polynucleotides, siRNA, shRNA, ribozymes, and DNAzymes. Disorders related to CXCL13 activity include inflammatory disorders, such as pulmonary disorders, for example, asthma, emphysema, and COPD, and systemic lupus erythematosus.

Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.